The ESMO Advanced Course on Cholangiocarcinoma 2026, organized by the European Society for Medical Oncology (ESMO), will take place on November 13–14, 2026, in Barcelona, Spain.

The course is designed to provide an advanced multidisciplinary update on the diagnosis and management of cholangiocarcinoma, covering diagnostic challenges, clinical and molecular differences between disease subtypes, adjuvant and palliative treatment strategies, surgery and other locoregional therapies, immunotherapy, and currently available and emerging targeted treatments for advanced disease.

The programme is aimed at oncology professionals seeking deeper practical knowledge of this complex malignancy and has been accredited with 11 ESMO-MORA Category 1 points.